デフォルト表紙
市場調査レポート
商品コード
1439976

フェムテックの世界市場:洞察、競合情勢、市場予測:2030年

FemTech - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
フェムテックの世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のフェムテックの市場規模は、2024年から2030年までの予測期間中に13.52%のCAGRで拡大すると予測されています。フェムテックの需要は、デジタルヘルスソリューションの採用の増加、人工知能とバーチャルアシスタンスの進歩、投資と資金調達の増加、個人の健康と衛生に対する女性の意識の高まり、女性の間での感染症の増加、政府や他の組織による大規模な投資などによって後押しされており、それによって2024年から2030年までの予測期間中にフェムテック市場の全体的な成長に寄与しています。

フェムテック市場は、様々な要因によって成長が促進されていますが、重要な要因の1つは、デジタル技術に対する需要の増加と個人によるこれらの技術サービスの採用です。

近年、あらゆる層でインターネットとスマートフォンの利用が増加しています。フェムテック技術の主な目的は、世界中の女性の病気や要望に応えることです。

女性の困難をよりよく理解し診断するためにフェムテック技術が利用される結果、フェムテックサービスに対する大きな需要があります。フェムテック製品市場は、女性の健康管理のためにデジタル技術がさまざまな場所でどのように利用されているかによって牽引されています。

さらに、政府をはじめとする官民組織による投資の高まりが、市場の需要を後押しします。また、近年、女性の間で感染症が増加しており、フェムテック製品やサービスが感染症の管理、治療、診断に役立つことから、フェムテックに対する大きな需要が生じています。

当レポートでは、世界のフェムテック市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 フェムテック市場レポートのイントロダクション

第2章 フェムテック市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 フェムテック市場の主な要因分析

  • フェムテック市場の促進要因
  • フェムテック市場の抑制要因と課題
  • フェムテック市場の機会

第5章 フェムテック市場におけるポーターのファイブフォース分析

第6章 フェムテック市場の概要

  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 フェムテック市場の企業と製品プロファイル

  • HeraMED
  • Sera Prognostics
  • iSono Health, Inc.
  • Flo Health Inc.
  • NUVO Inc.
  • Natural Cycles USA Corp
  • Athena Feminine Technologies, Inc.
  • NUROKOR LIMITED
  • Canopie
  • Univfy Inc.
  • Glow Inc.
  • Clue by Biowink GmbH
  • Oura Health Oy.
  • Ava
  • Laboratory Corporation of America® Holdings
  • Baymatob Operations Pty. Ltd.
  • Expectful
  • Evofem Biosciences, Inc.
  • March Inc.
  • Syantra Inc.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Femtech Market in Global (2021-2030)
  • Table 3: Femtech Market in Global by Type (2021-2030)
  • Table 4: Femtech Market in Global by Application (2021-2030)
  • Table 5: Femtech Market in Global by End-User (2021-2030)
  • Table 6: Femtech Market in Global by Geography (2021-2030)
  • Table 7: Femtech Market in North America (2021-2030)
  • Table 8: Femtech Market in North America by Country (2021-2030)
  • Table 9: Femtech Market in the US (2021-2030)
  • Table 10: Femtech Market in Canada (2021-2030)
  • Table 11: Femtech Market in Mexico (2021-2030)
  • Table 12: Femtech Market in Europe (2021-2030)
  • Table 13: Femtech Market in Europe by Country (2021-2030)
  • Table 14: Femtech Market in France (2021-2030)
  • Table 15: Femtech Market in Germany (2021-2030)
  • Table 16: Femtech Market in the United Kingdom (2021-2030)
  • Table 17: Femtech Market in Italy (2021-2030)
  • Table 18: Femtech Market in Spain (2021-2030)
  • Table 19: Femtech Market in the Rest of Europe (2021-2030)
  • Table 20: Femtech Market in Asia-Pacific (2021-2030)
  • Table 21: Femtech Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Femtech Market in China (2021-2030)
  • Table 23: Femtech Market in Japan (2021-2030)
  • Table 24: Femtech Market in India (2021-2030)
  • Table 25: Femtech Market in Australia (2021-2030)
  • Table 26: Femtech Market in South Korea (2021-2030)
  • Table 27: Femtech Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Femtech Market in the Rest of the World (2021-2030)
  • Table 29: Femtech Market in RoW by Region (2021-2030)
  • Table 30: Femtech Market in the Middle East (2021-2030)
  • Table 31: Femtech Market in Africa (2021-2030)
  • Table 32: Femtech Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Femtech Market in Global (2021-2030)
  • Figure 3: Femtech Market in Global by Type (2021-2030)
  • Figure 4: Femtech Market in Global by Application (2021-2030)
  • Figure 5: Femtech Market in Global by End-User (2021-2030)
  • Figure 6: Femtech Market in Global by Geography (2021-2030)
  • Figure 7: Femtech Market in North America (2021-2030)
  • Figure 8: Femtech Market in North America by Country (2021-2030)
  • Figure 9: Femtech Market in the US (2021-2030)
  • Figure 10: Femtech Market in Canada (2021-2030)
  • Figure 11: Femtech Market in Mexico (2021-2030)
  • Figure 12: Femtech Market in Europe (2021-2030)
  • Figure 13: Femtech Market in Europe by Country (2021-2030)
  • Figure 14: Femtech Market in France (2021-2030)
  • Figure 15: Femtech Market in Germany (2021-2030)
  • Figure 16: Femtech Market in the United Kingdom (2021-2030)
  • Figure 17: Femtech Market in Italy (2021-2030)
  • Figure 18: Femtech Market in Spain (2021-2030)
  • Figure 19: Femtech Market in the Rest of Europe (2021-2030)
  • Figure 20: Femtech Market in Asia-Pacific (2021-2030)
  • Figure 21: Femtech Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Femtech Market in China (2021-2030)
  • Figure 23: Femtech Market in Japan (2021-2030)
  • Figure 24: Femtech Market in India (2021-2030)
  • Figure 25: Femtech Market in Australia (2021-2030)
  • Figure 26: Femtech Market in South Korea (2021-2030)
  • Figure 27: Femtech Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Femtech Market in the Rest of the World (2021-2030)
  • Figure 29: Femtech Market in RoW by Region (2021-2030)
  • Figure 30: Femtech Market in the Middle East (2021-2030)
  • Figure 31: Femtech Market in Africa (2021-2030)
  • Figure 32: Femtech Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0657

FemTech Market By Type (Devices, Software, And Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, And Others), By End-User (Hospitals, Fertility Clinics, Diagnostic Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rise of digital healthcare and high figures of chronic and infectious diseases among the female population

The global femtech market is estimated to grow at a CAGR of 13.52% during the forecast period from 2024 to 2030. The demand for femtech is being boosted by a rise in the adoption of digital health solutions, advancement in artificial intelligence and virtual assistance, growth in investments and funding, growing female awareness of personal health and hygiene, rising infectious diseases among women, large investments made by the government and other organizations, among others are thereby contributing to the overall growth of the femtech market during the forecast period from 2024-2030.

FemTech Market Dynamics:

The femtech market is witnessing growth owing to various factors, one of the key factors being the increasing demand for digital technology and the adoption of these technical services by individuals.

All demographic groups have shown growth in internet and smartphone use in recent years. Femtech technology's main objective is to meet the ailments and demands of women all over the world.

There is a significant demand for femtech services as a result of the usage of femtech technologies to better understand and diagnose women's difficulties. The market for femtech products has been driven by how digital technology is being used in different locations to manage women's health.

Additionally, the rising investments by the government and other public and private organizations will fuel market demand. Also, significant demand for femtech has been generated by the rise in infectious diseases among women in recent years as femtech products and services can help manage, treat, and diagnose infectious diseases

Further, the proliferation of mobile apps that keep track of fertility and pregnancy is a key factor boosting the market of femtech. The rising adoption of healthcare strategies that aim to boost the participation of women in clinical studies is also boosting the market of femtech.

In addition, investors are concentrating more on providing funds for programs that benefit women's health and well-being. For instance, Maven Clinic, a teletherapy firm with a focus on women's health, raised USD 90 million in Series E fundraising in November 2022, in the year's largest Femtech deal. Maven has reportedly raised more than USD 300 million in total capital.

Also, in July 2021, the US FDA approved and gave clearance to Natural Cycles to use body temperature data readings collected by smart wearables, such as Oura smart ring, for assessing a woman's fertility and managing pregnancy.

Therefore, the above-mentioned factors are contributing to the growth of the Femtech market during the forecast period from 2024-2030.

However, cybersecurity and privacy concerns, lack of awareness about femtech products and applications in developing nations, and others may restrict the femtech market growth.

The femtech market was significantly impacted during the period of the COVID-19 pandemic. During the initial stage of the pandemic, the sale of femtech suffered a collapse owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. Moreover, the outbreak of the pandemic led to the cancellation of outpatient visits for diagnosis, treatment, and management of various reproductive and gynecological ailments. However, with the growing incorporation of telehealth services in the healthcare industry and the availability of various femtech products over e-commerce, the demand for femtech increased suddenly. Thus, owing to the sudden increase, the market players focused on their strategic initiatives to expand their competitive edge in the market, thereby bringing the market of femtech on track. Thus, the aforementioned factors propelled the demand for femtech devices and services during the pandemic and are estimated to do the same in the upcoming years.

FemTech Market Segment Analysis:

Femtech market by Type (Devices, Software, and Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, and Others), End-User (Hospitals, Fertility Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the femtech market, the reproductive health category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the increasing prevalence of various reproductive ailments and the incorporation of femtech devices and services in the management of reproductive diseases.

For instance, the total fertility rate (TFR) of Filipino women aged 15 to 49 years decreased to 1.7 children per urban woman and 2.2 children per rural woman in 2022 from the previous ten years, according to data released by the Government of the Philippines in November 2022. As a result, the Philippines' fertility rate is currently below the replacement threshold of 2.1 children per woman.

Thus, owing to the rise in female infertility rates, there is a growing need among end users for femtech services, goods, and programs. Thus, it is anticipated to fuel segment growth throughout the forecast period.

Further, the need for femtech solutions for reproductive health is anticipated to expand due to several causes, including the older age of women and environmental variables, which lead to an increase in the number of women having problems before, during, or after pregnancy. Also, owing to a greater emphasis on employment and later marriage, there is currently a trend for women to get pregnant at a later age.

Furthermore, the increase in investment toward reproductive health-related apps and devices, initiatives taken by major governments worldwide, the surging launch of femtech services and devices, and others are also expected to propel the segment growth. For instance, in September 2022, Embr Labs entered into a strategic partnership to launch an innovative women's health product to provide immediate relief from hot flashes during menopause. Embr Wave 2, a sleek wearable that cools or warms at the touch of a button, will now be made available to women in the United Kingdom.

Therefore, the aforementioned factors are predicted to contribute to the increasing demand for this segment thereby driving the growth of the overall femtech market during the forecast period.

North America is expected to dominate the overall FemTech Market:

Among all the regions, North America is estimated to account for the largest share of the global Femtech market in the year 2023. Owing to the factors such as the high prevalence of cancer among women, rising incidence of lifestyle-related disorders, high adoption of technologically advanced products, and others are expected to aid in the growth of the North America femtech market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and growing awareness about femtech products and services among the target population in the region, also helped the market growth in this region.

According to the women's health data that the CDC evaluated in 2022, 12.7% of women in the United States who are 18 or older smoke regularly, 41.8% of women who are 20 or older were obese, and 45.2% of women had hypertension, in 2021. The majority of the people in the region are now inclined towards femtech products and services to overcome infertility because these factors are associated with female infertility. Thus, the above factor is anticipated to fuel the growth of the femtech market in the North America region.

Further, with expanding smartphone penetration and demand for smart health solutions, the healthcare industry in North America has seen rapid digitalization. For instance, the estimates from Mobile Economy North America 2021 indicate that there were 296 million mobile internet users in North America in 2020, and the figure will rise to 323 million by 2025. Thus, the North American femtech market is anticipated to expand as a result of the rising preventative care use, rising health consciousness & awareness, and rising usage of smart wearable devices and mobile health applications for health tracking.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, investments, and others also help in boosting regional product demand. For instance, in August 2022, a United States-based femtech startup scored USD 3.2 million in seed funding in a round led by Thiel Capital with a fitness and wellness pitch that aims to connect women to the hormonal phases of their menstrual cycle for physical and emotional gain.

Also, in March 2021, Clue received the U.S. FDA clearance for the launch of Clue Birth Control-a digital contraceptive built-in Clue application that can predict ovulation statistically by using a tool for birth control. Thus, such strategic steps help to increase the demand for femtech, thereby driving the North America femtech market forward during the forecast period.

FemTech Market Key Players:

Some of the key market players operating in the femtech market include HeraMED, Sera Prognostics, iSono Health, Inc., Flo Health Inc., NUVO Inc., Natural Cycles USA Corp, Athena Feminine Technologies, Inc., NUROKOR LIMITED, Canopie, Univfy Inc., Glow Inc., Clue by Biowink GmbH, Oura Health Oy., Ava, Laboratory Corporation of America® Holdings, Baymatob Operations Pty. Ltd., Expectful, Evofem Biosciences, Inc., March Inc., Syantra Inc., and others.

Recent Developmental Activities in the FemTech Market:

In November 2022, London-based accelerator FemTech Lab launched an innovation space for the FemTech community. The FemTech Hub is the first physical innovation hub dedicated to women's health, especially.

In June 2022, companies in Japan introduced "Femtech" or "Female technology," under which attention is being paid to the health of female employees. This initiative was undertaken by the Ministry of Economy, Trade, and Industry in Japan.

In April 2022, a femtech startup, Conceive, received USD 3.7 million in funding that would be used for its outcomes-oriented fertility solution.

In August 2021, LabCorp, a leading global life sciences company, acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy, and parenting.

Key Takeaways from the FemTech Market Report Study

Market size analysis for current femtech market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global femtech market.

Various opportunities available for the other competitor in the femtech market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current femtech market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for femtech market growth in the coming future?

Target Audience who can be benefited from this FemTech Market Report Study

Femtech products providers

Research organizations and consulting companies

Femtech-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in femtech

Various End-users who want to know more about the femtech market and the latest technological developments in the femtech market.

Frequently Asked Questions for the FemTech Market:

1. What is femtech?

Femtech refers to the tools and programs that support women's health and well-being. Numerous applications involving reproductive systems, fertility challenges, pregnancy, and other women's healthcare issues can make use of these tools and solutions.

2. What is the market for global femtech?

The global femtech market is estimated to grow at a CAGR of 13.52% during the forecast period from 2024 to 2030.

3. What are the drivers for the global femtech market?

The demand for femtech is primarily being heightened by the growing health consciousness amongst the female population, normalizing & proactively addressing women's health issues, increasing disposable income, digital literacy, smartphone penetration, internet connectivity, digital health infrastructure, the growing availability of smart wearable devices, among others, thereby contribute to the overall growth of the femtech market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Femtech market?

Some of the key market players operating in the femtech market include HeraMED, Sera Prognostics, iSono Health, Inc., Flo Health Inc., NUVO Inc., Natural Cycles USA Corp, Athena Feminine Technologies, Inc., NUROKOR LIMITED, Canopie, Univfy Inc., Glow Inc., Clue by Biowink GmbH, Oura Health Oy., Ava, Laboratory Corporation of America® Holdings, Baymatob Operations Pty. Ltd., Expectful, Evofem Biosciences, Inc., March Inc., Syantra Inc., and others.

5. Which region has the highest share in the femtech market?

North America is expected to dominate the overall femtech market during the forecast period from 2024-2030. Factors such as the rising prevalence of chronic diseases among women, increasing infertility, and growing awareness about femtech products and services among the target population, among others will positively impact the North American femtech market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about women's health also helped the market growth in this region.

Table of Contents

1.Femtech Market Report Introduction

2. Femtech Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Femtech Market Key Factors Analysis

  • 4.1. Femtech Market Drivers
    • 4.1.1. Rising adoption of digital health solutions
    • 4.1.2. Advancements in artificial intelligence and virtual assistance
    • 4.1.3. Growing availability of smart wearable devices
  • 4.2. Femtech Market Restraints and Challenges
    • 4.2.1. Cybersecurity and privacy concerns
    • 4.2.2. Lack of awareness about femtech products and applications in developing nations
  • 4.3. Femtech Market Opportunities
    • 4.3.1. The emergence of start-ups focusing on women's health
    • 4.3.2. Growth in investments and funding in the femtech industry

5. Femtech Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Femtech Market Layout

  • 6.1. By Type
    • 6.1.1. Devices
    • 6.1.2. Software
    • 6.1.3. Services
  • 6.2. By Application
    • 6.2.1. Reproductive Health
    • 6.2.2. Pregnancy & Nursing care
    • 6.2.3. Pelvic & Uterine Healthcare
    • 6.2.4. General Healthcare & Wellness
    • 6.2.5. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Fertility Clinics
    • 6.3.3. Diagnostic Centers
    • 6.3.4. Others
  • 6.4. By Geography
    • 6.4.1. North America Femtech Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Femtech Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Femtech Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Femtech Market Size in USD million (2021-2030)
    • 6.4.2. Europe Femtech Market Size in USD million (2021-2030)
      • 6.4.2.1. France Femtech Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Femtech Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Femtech Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Femtech Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Femtech Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Femtech Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Femtech Market Size in USD million (2021-2030)
      • 6.4.3.1. China Femtech Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Femtech Market Size in USD million (2021-2030)
      • 6.4.3.3. India Femtech Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Femtech Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Femtech Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of the Asia-Pacific Femtech Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Femtech Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Femtech Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Femtech Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Femtech Market Size in USD million (2021-2030)

7. Femtech Market Company and Product Profiles

  • 7.1. HeraMED
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Sera Prognostics
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. iSono Health, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Flo Health Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. NUVO Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Natural Cycles USA Corp
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Athena Feminine Technologies, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. NUROKOR LIMITED
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Canopie
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Univfy Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Glow Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Clue by Biowink GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Oura Health Oy.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Ava
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Laboratory Corporation of America® Holdings
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Baymatob Operations Pty. Ltd.
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Expectful
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Evofem Biosciences, Inc.
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. March Inc.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Syantra Inc.
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us